COVID-19

The US Food and Drug Administration (FDA) is currently investigating whether the new COVID-19 variant will evade current mitigation strategies and diagnostic tools.

Educate patients about the safety of receiving the seasonal influenza and COVID-19 vaccine at the same time.

Kristen Nichols, PharmD, and senior content management consultant for clinical effectiveness at Wolters Kluwer joins Drug Topics® to discuss the benefits of the coadministration of COVID-19 and flu vaccines in part 2 of this interview.

The Omicron variant was first identified in South Africa on November 24, 2021.

The Omicron variant of COVID-19 is spreading quickly, jumping continents through infected travelers. Here’s the latest on what global health officials know.

Non-hospitalized symptomatic COVID-19 patients who were treated with ciclesonide to alleviate early symptoms did not see any difference in results compared to patients who were treated with a placebo of the drug.

Nearly one-third of hospital personnel had still not been vaccinated against COVID-19 by mid-September.

The EUA amendment was granted for both the Pfizer-BioNTech and Moderna vaccines.

The EUA submission includes data from the company’s interim analysis of the Phase 2/3 EPIC-HR clinical trial.

Misinformation about the disease and vaccinations remains widespread, and correlated with party affiliation.

Not every vaccine is required, some are just strongly recommended. Here's what to know about 5 recommended vaccines.

The vaccine mandate applies to employees at facilities that participate in the Medicare and Medicaid insurance programs.

Although the authors say their findings shed light on possible disruptions to insulin supply during COVID-19, they note they could not adjust for those with diabetes who died.

The company plans to submit these results to the FDA and EMA for review.

After a panel federal judges put a temporary halt on the mandate, the U.S. Surgeon General says the administration is ready to fight for the requirement.

Patients with post-acute COVID syndrome, or “long COVID,” can experience symptoms for at least 12 months, investigators reported.

Here’s a roundup of the latest news from Drug Topics®.

"The spread of misinformation and mistrust in doctors and science is contributing to staggeringly low vaccination rates among pregnant people," said the American Colleges of Obstetricians and Gynecologists.

The FDA and CDC have both issued their respective recommendations for the rollout of Pfizer-BioNTech and Moderna COVID-19 vaccine boosters.

Merck and Ridgeback Biotherapeutics have announced their submission of an EUA application to the FDA for an oral antiviral medication for the treatment of COVID-19.

Good Neighbor Pharmacy customers from rural, suburban, and city areas reflect on the past year and discuss the future of independent pharmacy.

Prioritizing well-being can be difficult when dealing with increased workloads, but pharmacists can find small ways to incorporate self-care into their days.

Good Neighbor Pharmacy (GNP) has allocated more than 2 million doses of COVID-19 vaccines to more than 1500 independent pharmacies through its partnership with the Federal Retail Pharmacy Program.

The FDA EUA for the COVID-19 vaccine will remain in effect for those 12 to 15 years of age and for the administration of a third dose.

A study published in JAMA Internal Medicine explained that a first dose reaction to COVID-19 vaccination should not deter people from receiving their second dose.